http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103254142-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40285e27f4ed83b8728b0d477404958
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6408da561b78ce66aa196f5debfac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e87be85e2f3de2c2c90a45c642f93ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac8b96c1340fffbfd402e092b1bef1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b89fd36b9f1b25d069e1344284622ef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_782f46d0be51b6bb13bc1b3fbfe5c965
publicationDate 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103254142-A
titleOfInvention 4-[4-(2-substituted aminoacetamido)anilino]quinazoline derivatives and their preparation and application
abstract The invention discloses a 4-[4-(2-substituted aminoacetamido)anilino]quinazoline derivative and its preparation and application. The 4-[4-(2-substituted aminoacetamido)anilino ] quinazoline derivatives have the following general structural formula (I), in the general structural formula (I), R is in dimethylamino, diethylamino, dipropylamine, morpholinyl or m-toluidine One; X is H or Cl. The 4-[4-(2-substituted aminoacetamido)anilino]quinazoline derivatives of the invention can be used to prepare medicines for preventing or treating human lung cancer or human breast cancer, and have good anticancer activity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110546147-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110546147-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10273227-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109942499-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108129460-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109942499-A
priorityDate 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102686581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102625797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012245173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013020062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2489661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2433931-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415897172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466379311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466379310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241520

Total number of triples: 34.